:::::::Indiana Cannabis Reform Legislation::::::

[armedoldhippy]

Florida House Panel Passes Bill To Restrict Hemp-Derived Products Over Patients’ Objections

“Only through hemp and its derivatives such as delta-8, delta-9, CBD, its derivatives, and medicinal THC, I’ve been able to actually stand here before you today, prescription drug free.” By Mitch Perry, Florida Phoenix Kassie Stuart was 17 years old when she was diagnosed with idiopathic genetic...

www.marijuanamoment.net

and right there in her opening statement is why they restricted it. "prescription drug free". is it irony or what, when the same people that want you to take off-label drugs meant for horses instead of approved treatments get mad if you don't need/want the medicines they are trying to sell you... conflict of interest much ???

 

[pipeline]

House discusses HB 1079 at 50:00 time mark on Jan 31.

 

[pipeline]

The psilocybin therapy research bill passed the Health and Provider Services committee and is going to the Appropriations Committee, where it will be heard tomorrow Feb 1.

*SB0139.1*
January 19, 2024
SENATE BILL No. 139
_____
DIGEST OF SB 139 (Updated January 17, 2024 12:11 pm - DI 104)
Citations Affected: IC 16-18; IC 16-46.

Synopsis: Psilocybin treatment program. Establishes the therapeutic
psilocybin research fund, administered by the Indiana department of
health (state department), to provide financial assistance to research
institutions in Indiana to study the use of psilocybin to treat mental
health and other medical conditions. Sets forth clinical study
requirements. Requires a research institution that receives a grant to
conduct a clinical study to prepare and submit a report to the interim
study committee on public health, behavioral health, and human
services, the state department, and the division of mental health and
addiction.

Effective: Upon passage.
Charbonneau, Johnson T
January 8, 2024, read first time and referred to Committee on Health and Provider
Services.
January 18, 2024, amended, reported favorably — Do Pass; reassigned to Committee on
Appropriations

 

[pipeline]

Bill passed senate comittee, so I think it will to House and Senate Chamber floors for discussion and vote now.

SB 139
Psilocybin treatment program.

Sen. Ed CharbonneauSen. Tyler Johnson

DO PASS AMEND
Yeas: 14; Nays: 0; (Voted on Feb. 1)

 

[pipeline]

Another Indiana Senate Committee Passes Psilocybin Research Bill, Sending It To The Floor

Another Indiana Senate panel has unanimously approved a bill that would fund clinical research trials into psilocybin. The Senate Appropriations Committee adopted a technical amendment before sending the legislation to the floor in a 14-0 vote. The action follows the psychedelics proposal being...

www.marijuanamoment.net

Published
15 mins ago
on
February 1, 2024
By
Tom Angell

Another Indiana Senate panel has unanimously approved a bill that would fund clinical research trials into psilocybin.


The Senate Appropriations Committee adopted a technical amendment before sending the legislation to the floor in a 14-0 vote. The action follows the psychedelics proposal being passed, also unanimously, by the Senate Health and Provider Services Committee last month.


“Psilocybin has been given breakthrough therapy by the FDA and it’s not a fringe service…anymore,” Sen. Ed Charbonneau (R), the bill’s sponsor, said ahead of Thursday’s latest vote.



“Research institutes would be able to apply for the funds to conduct studies to evaluate efficacy of psilocybin as an alternative treatment for PTSD and combat veterans and first responders with anxiety, depression, bipolar disorder, chronic pain and migraines,” he said. “It’s something that’s out there that is providing hope for for individuals who suffer with these issues. And right now there isn’t a lot of hope for them, and I look at psilocybin is a good thing.”


If it becomes law, the measure would create a therapeutic psilocybin research fund “for the purpose of providing financial assistance to research institutions in Indiana to study…the use of psilocybin to treat mental health and other medical conditions.” Any research receiving funding under the bill would need to include veterans and first responders regarding in the study sample.



Researchers would need to apply to the state Department of Health to receive funds to study the substance as a treatment for conditions, six of which are specified in the bill: PTSD “with a focus on treating the disorder in combat veterans and first responders,” anxiety, depression, bipolar disorder, chronic pain and migraines.


The studies would need to “compare the efficacy of psilocybin as a treatment for mental health and other medical conditions…with the efficacy of other current treatment options.”


The bill would become effective immediately upon passage, as it was filed as an emergency measure. Officials would need to establish a process to administer the fund and process applications by July 1.


Before approving the legislation on Thursday, the Appropriations Committee adopted an amendment making technical changes to how money would be appropriated to the fund. The bill’s next stop is the Senate floor, after which point it would potentially head to the House of Representatives.

At the bill’s prior committee stop, former Indiana State Health Commissioner Richard Feldman said that using psychedelics to treat behavioral disorders “may sound like a pretty crazy thing to do on first consideration. That’s what I thought when I first heard about this.”

“But recent studies have shown impressive results conducted by respected institutions, and reported in mainstream publications,” he added. “Examples include the New England Journal of Medicine, the Journal of Psychopharmacology and the Journal of American Medical Association. Authoring institutions include Harvard, Hopkins, and New York University among others. This is in no way fringe science.”


A state-created study committee recently recommended that lawmakers authorize a psilocybin pilot program to research psychedelic-assisted therapy for mental health during this year’s legislative session, advising that “the Indiana General Assembly take an approach that strikes a balance between access, research, and prudence.”

While psilocybin is classified as a Schedule I controlled substance at the federal level, the body said, the “prevailing view is that psilocybin should not be a Schedule I drug and has proven medical benefits.”

Charbonneau said late last year that he was already in touch with people at Indiana University Health and Purdue University about psychedelic research.

“I have had discussions with both IU Health and with Purdue University,” he said. “I spoke to 150 pharmacy students at Purdue, and afterward had a chance to speak with the dean of the pharmacy program…and he texted Dr. Jerome Adams, who’s now at Purdue University.”


Adams, a former U.S. surgeon general under then-President Donald Trump, joined Purdue in October 2021. While he’s said little publicly about psychedelic-assisted therapy, he’s previously claimed that “there’s no such thing as medical marijuana.”

Indiana lawmakers have been considering marijuana legalization but so far have yet to take concrete steps toward the reform in the GOP-controlled legislature. Another interim study group heard testimony around the possibility of decriminalizing simple cannabis possession in November, but the group did not make any specific recommendations.


In an op-ed for Marijuana Moment, Rep. Blake Johnson (D) wrote recently that Indiana is “falling far behind” on marijuana as its neighboring states legalize. “I implore my fellow legislators to listen to the statistics. It’s time for Indiana to sow the seeds and reap the economic benefits of cannabis,” he wrote.

One supportive lawmaker—Rep. Justin Moed (D)—managed to force a vote on marijuana legalization in the House last year, but Republicans rejected the proposal.

 

[pipeline]

This is what made me so upset, when I heard about the psilocybin bill in November, after Ohio had legalized adult use cannabis. I thought, how is it that the state doesn't research and talk honestly about cannabis as a medicine?

There was quite a difference in how they discussed cannabis compared to psilocybin mushroom treatment research. There was little reguard for patient's needs when the discussion was about cannabis, and they went agains the doctor's recommndations. It was the same doctor who spoke in support of the decriminalization bill and in support of the psilocybin treatment research hearings.

 

[revegeta666]

If all of us fought as hard as you, weed would be legal worldwide. Hope you're doing good my friend

 

[pipeline]

Indiana Democrat Forces Marijuana Legalization Vote In House, But GOP Lawmakers Reject It

Indiana Democratic lawmakers came up with a crafty way to force a House vote on marijuana legalization on Thursday after Republican leadership has blocked the issue from being considered in session after session, though the chamber ultimately rejected the reform. The House took up Senate Bill...

www.marijuanamoment.net

Indiana Democrat Forces Marijuana Legalization Vote In House, But GOP Lawmakers Reject It​

Published
10 months ago
on
April 6, 2023
By
Kyle Jaeger

."Moed said that Democrats would continue to work to advance marijuana reform, and he’d support having a conversation about starting with decriminalization if Republicans were willing to take it up seriously.



“I think those of us in the Democratic caucus, we believe we need to take action in some way—and we’re open, certainly, to whatever compromises and negotiating we have to do to get the ball move forward,” he said. “But we certainly just don’t believe that people who are seeking medical relief or have very low amounts of cannabis product for whatever reason— whether it’s mental health or veterans—no one should be a criminal for doing that.”


“I think that this today was an effort to try to kind of give those people a voice in the legislature because it’s been stifled up to this point,” he said. “And, unfortunately, when put to a full vote, even a lot of people who said they were for it didn’t take the vote.”

 

[pipeline]

Kind of find it funny they aren't finding it necessary to study Cannabis since its legal and widely studied, the medical benefits are well known in the USA. However, the the representative legislators ignore the needs of those patients who benefit from cannabis.

Could this be discrimination? Maybe there could be lawsuits to get some accountability.

 

[pipeline]

Wait a minute, they passed a Psilocybin research bill which provides funding grants to research institutions ( IU Health, Purdue University), but this year no changes in budget are able to be made. Maybe they have a research grant fund they can draw from for funding.

House leaders have said cannabis reform would not be an issue they are able to take up this year, becuase they made a 2-year budget plan last year.

 

[pipeline]

Also participants in the psilocybin research have to be veterans or first responders. Why would they exclude other people who have different types of issues to study who could also benefit from the treatment?

 

[armedoldhippy]

because they made a 2-year budget plan last year.

they will ALWAYS have an excuse...bastards.

 

[armedoldhippy]

Also participants in the psilocybin research have to be veterans or first responders.

PTSD victims, got it. camels nose under the tent. gotta start somewhere...

 

[pipeline]

I'm glad they got this passed. I have a friend who travels every year to get hallucinogen therapy using Iboga. I had never heard about it before he told me about his therapy!

This psilocybin bill is fantastic! Hope they make this treatment available to the public as soon as possible!

They said it has a very favorable safety profile. Sounds like many people could benefit from it.

 

[pipeline]

Sec. 6. (a) A research institution in Indiana may apply to the
5 state department to receive financial assistance from the fund to
6 conduct one (1) or more clinical studies to evaluate the efficacy of
7 psilocybin as an alternative treatment for mental health and other
8 medical conditions, including the following:
9 (1) Posttraumatic stress disorder, with a focus on treating the
10 disorder in combat veterans and first responders.
11 (2) Anxiety.
12 (3) Depression.
13 (4) Bipolar disorder.
14 (5) Chronic pain.
15 (6) Migraines.
16 (b) In conducting a clinical study under this section, a research
17 institution that receives a grant under this chapter shall do the
18 following:
19 (1) Include veterans and first responders in the study sample.
20 (2) Evaluate and determine whether psilocybin is an effective
21 treatment for mental health and other medical conditions
22 described in subsection (a).
23 (3) Compare the efficacy of psilocybin as a treatment for
24 mental health and other medical conditions described in
25 subsection (a) with the efficacy of other current treatment
26 options for mental health and other medical conditions
27 described in subsection (a).
28 (4) Before entering the study, require each participant to
29 undergo a mental health evaluation.
30 Sec. 7. After a research institution that receives a grant under
31 this chapter completes and finalizes a study under this chapter, a
32 research institution shall prepare and submit a report
33 summarizing the results of the study and any recommendations for
34 legislation to the following:
35 (1) The interim study committee on public health, behavioral
36 health, and human services established by IC 2-5-1.3-4 in an
37 electronic format under IC 5-14-6.
38 (2) The state department.
39 (3) The division of mental health and addiction.
40 Sec. 8. Not later than July 1, 2024, the state department shall
41 establish a process to administer the fund and process a

 

[armedoldhippy]

have dealt/currently dealing with numbers 11, 12, 14, and 15. i could alleviate 11 and 12 by not reading news, but being uninformed is not my style. #15 is under control, while #14 will keep getting worse. "life sucks, then you die. "

 

[pipeline]

 

[pipeline]

 

[revegeta666]

@pipeline Those are some pretty colours! What strain is that?

 

[pipeline]

Thanks. That's Sativa Candy Chunk F14.